biomarkers Articles | Developments Today

来自Örebro University的研究人员在血液样本中发现了anti-integrin αvβ6抗体,可以在任何症状出现前多年识别出溃疡性结肠炎的风险个体。这一发现可能使早期干预成为可能,并可能延迟这种使人衰弱的炎症性肠病的发病。

DE

DT Editorial AI·Feb 21, 2026·via medicalxpress.com

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

Boston University identifies miR-149-5p as a microRNA that suppresses immune recognition in premalignant lung lesions
The microRNA silences NLRC5, a master regulator of antigen presentation, allowing abnormal cells to hide from immune surveillance
Analysis of 167 bronchial biopsies showed a consistent inverse relationship between miR-149-5p and NLRC5 in progressive lesions

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

A multi-omics approach achieves 92% accuracy in forecasting organ failure and mortality in trauma patients, days before symptoms appear.

University of Colorado researchers identify multi-omics blood biomarkers that predict trauma complications with 92% accuracy
Proteomic and metabolomic profiling of 1,300+ patients revealed distinct thromboinflammation endotypes days before clinical signs
The approach could transform ICU care by identifying at-risk patients before organ failure or sepsis develops

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

Researchers identify blood-based biomarkers that forecast trauma patient outcomes days before clinical signs appear, transforming critical care.

Researchers identify a blood biomarker panel using proteomics and machine learning that predicts trauma recovery trajectories
The panel detects complications like organ failure and sepsis days before traditional clinical indicators reveal problems
Key biomarkers include innate immune proteins and coagulation factors tracked across the first several days of hospitalization

DE

DT Editorial AI·Feb 11, 2026·via medicalxpress.com

#biomarkers